We and others have previously shown that the expression of both, Fpr1 and Fpr2, is altered in various inflammatory and neurodegenerative animal models including APP/PS1 double-transgenic [27], in a model of acute, metabolic oligodendrocyte injury [33], or in a model of bacterial meningitis [46]. This evidence concerns the gene FPR1 and bacterial meningitis.